|
15-05-2024
|
|
|
|
| Sequent Scientific Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024. |
|
|
|
|
|
15-05-2024
|
|
|
|
| Sequent Scientific Limited has informed the Exchange about Investor Presentation |
|
|
|
|
|
15-05-2024
|
|
|
|
| Sequent Scientific Limited has informed the Exchange regarding Board meeting held on May 15, 2024.regarding audited financial result for March 2024 |
|
|
|
|
|
13-05-2024
|
|
|
|
| Sequent Scientific Limited has informed the Exchange about Schedule of meet |
|
|
|
|
|
09-05-2024
|
|
|
|
| SEQUENT SCIENTIFIC LIMITED has informed the Exchange about Board Meeting to be held on 15-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
|
|
|
|
|
07-05-2024
|
|
|
|
| SEQUENT: The Exchange had sought clarification from Sequent Scientific Limited with respect to announcement dated 10-Apr-2024, regardingﾠproviding guarantee and pledging of equity shares of its Indian Subsidiaries. On basis of above the Company was required to clarify following: a) name of party for which such guarantees or indemnity or surety was given; b) whether the promoter/ promoter group/ group companies have any interest in this transaction? If yes, nature of interest and details thereof and whether the same is done at arm's length; c) brief details of such guarantee or indemnity or becoming a surety viz. brief details of agreement entered (if any) including significant terms and conditions, including amount of guarantee; d) impact of such guarantees or indemnity or surety on listed entity. The response of the Company is attached. |
|
|
|
|
|
29-04-2024
|
|
|
|
| SEQUENT: The Exchange has sought clarification from Sequent Scientific Limited with respect to announcement dated 10-Apr-2024, regardingï¿‚ï¾ providing guarantee and pledging of equity shares of its Indian Subsidiaries. On basis of above the Company is required to clarify following:ï¿‚ï¾ a) name of party for which such guarantees or indemnity or surety was given; b) whether the promoter/ promoter group/ group companies have any interest in this transaction? If yes, nature of interest and details thereof and whether the same is done at arm's length; c) brief details of such guarantee or indemnity or becoming a surety viz. brief details of agreement entered (if any) including significant terms and conditions, including amount of guarantee; d) impact of such guarantees or indemnity or surety on listed entity. The response of the Company is awaited. |
|
|
|
|
|
25-04-2024
|
|
|
|
| Sequent Scientific Limited has informed the Exchange regarding Appointment of Mr Vedprakash Ragete as Executive Director of the company w.e.f. April 17, 2024. |
|
|
|
|
|